Who owns BENITEC BIOPHARMA INC?
- Ticker: BNTC
- CUSIP Number: 08205p209
Tip: Access positions for across all investors
Analyze quarterly positions in Benitec Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Benitec Biopharma stock
Who bought or sold BENITEC BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Suvretta Capital Management | 9.0M | $113M | 1% | Dec 2024 |
|
| Franklin Resources | 2.9M | $37M | 269% | Dec 2024 |
|
| Henderson Group | 2.6M | $33M | 199% | Dec 2024 |
|
| Adage Capital Partners GP | 2.0M | $25M | 134% | Dec 2024 |
|
| Nantahala Capital Management | 838k | $11M | 0% | Dec 2024 |
|
| Vanguard Group | 300k | $3.8M | 41% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 260k | $3.3M | -5% | Dec 2024 |
|
| Infinitum Asset Management | 210k | $2.7M | 100% | Dec 2024 |
|
| Geode Capital Management | 197k | $2.5M | 135% | Dec 2024 |
|
| BlackRock | 174k | $2.2M | 515% | Dec 2024 |
|
| AWM Investment Company | 102k | $1.3M | -84% | Dec 2024 |
|
| GAMMA Investing | 78k | $6.0M | 1104% | Mar 2025 |
|
| Simplify Asset Management | 76k | $964k | -34% | Dec 2024 |
|
| Lion Point Capital | 62k | $783k | 59% | Dec 2024 |
|
| MYDA Advisors | 50k | $632k | 100% | Dec 2024 |
|
| Morgan Stanley | 42k | $535k | 3100% | Dec 2024 |
|
| Northern Trust | 38k | $483k | 54% | Dec 2024 |
|
| 683 Capital Management | 36k | $452k | 100% | Dec 2024 |
|
| Ameriprise Financial | 36k | $448k | 138% | Dec 2024 |
|
| Susquehanna International | 25k | $313k | 100% | Dec 2024 |
|
| Qube Research & Technologies | 21k | $264k | 100% | Dec 2024 |
|
| State Street Corporation | 16k | $203k | 100% | Dec 2024 |
|
| Citigroup | 13k | $157k | 100% | Dec 2024 |
|
| UBS Group | 5.0k | $63k | 161% | Dec 2024 |
|
| Tower Research Capital | 1.1k | $14k | 378% | Dec 2024 |
|
| Goss Wealth Management | 671.00 | $8.5k | 10% | Dec 2024 |
|
| Rhumbline Advisers | 186.00 | $2.4k | 0% | Mar 2025 |
|
| Royal Bank of Canada | 173.00 | $2.0k | 100% | Dec 2024 |
|
| Bank of America Corporation | 148.00 | $1.9k | 118% | Dec 2024 |
|
| Group One Trading | 89.00 | $1.1k | 0% | Dec 2024 |
|
Who sold out of Benitec Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2024 | 60k | $551k |
| Longwood Capital Partners | Sep 2024 | 30k | $274k |
| Citadel Advisors | Sep 2024 | 14k | $131k |